DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Eplerenone

Eplerenone

  • COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-Cov-2 Infection

    COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-Cov-2 Infection

  • Oregon Medicaid PA Criteria for Fee-For-Service Prescriptions

    Oregon Medicaid PA Criteria for Fee-For-Service Prescriptions

  • Eplerenone Prevented Obesity- Induced Inflammasome Activation and Glucose Intolerance

    Eplerenone Prevented Obesity- Induced Inflammasome Activation and Glucose Intolerance

  • Cytochrome P450 3A Time-Dependent Inhibition Assays

    Cytochrome P450 3A Time-Dependent Inhibition Assays

  • Randomized, Placebo-Controlled Trial of the Effects of Drospirenone

    Randomized, Placebo-Controlled Trial of the Effects of Drospirenone

  • Interactions with HBV Treatment

    Interactions with HBV Treatment

  • New Mesh Headings for 2019 Listed in Alphabetical Order with Heading, Scope Note, Annotation (AN), Previous Indexing (PI), and Tree Locations

    New Mesh Headings for 2019 Listed in Alphabetical Order with Heading, Scope Note, Annotation (AN), Previous Indexing (PI), and Tree Locations

  • Selection of a Mineralocorticoid Receptor Antagonist for Patients with Hypertension Or Heart Failure

    Selection of a Mineralocorticoid Receptor Antagonist for Patients with Hypertension Or Heart Failure

  • OUH Formulary Approved for Use in Breast Surgery

    OUH Formulary Approved for Use in Breast Surgery

  • Cytochrome P450 Drug Interaction Table

    Cytochrome P450 Drug Interaction Table

  • Appendix B - Product Name Sorted by Applicant

    Appendix B - Product Name Sorted by Applicant

  • Your 2021 Premium Value Formulary Effective July 1, 2021

    Your 2021 Premium Value Formulary Effective July 1, 2021

  • INSPRA® (Eplerenone) Tablets, for Oral Use Initial U.S

    INSPRA® (Eplerenone) Tablets, for Oral Use Initial U.S

  • Comparative Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Heart Failure: a Network Meta-Analysis of Randomized Controlled Trials

    Comparative Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Heart Failure: a Network Meta-Analysis of Randomized Controlled Trials

  • Acute Otitis Media — No Antibiotics Does Not Equal No Treatment!

    Acute Otitis Media — No Antibiotics Does Not Equal No Treatment!

  • 3 INSPRA Eplerenone Tablets DESCRIPTION INSPRA Contains Eplerenone, a Blocker of Aldosterone Binding at the Mineralocorticoi

    3 INSPRA Eplerenone Tablets DESCRIPTION INSPRA Contains Eplerenone, a Blocker of Aldosterone Binding at the Mineralocorticoi

  • Drospirenone for Oral Contraception and Hormone Replacement Therapy Are Its Cardiovascular Risks and Benefits the Same As Other Progestogens?

    Drospirenone for Oral Contraception and Hormone Replacement Therapy Are Its Cardiovascular Risks and Benefits the Same As Other Progestogens?

  • Eplerenone for NYHA Class II Heart Failure

    Eplerenone for NYHA Class II Heart Failure

Top View
  • Efficacy of Drug Eplerenone in the Management of Chronic Central Serous Chorioretinopathy
  • Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
  • Update Aldosterone-Renin Test Aldosterone-To-Renin Ratio
  • New Zealand Data Sheet
  • 19Th Expert Committee on the Selection and Use of Essential Medicines April 8‐12 2013
  • Eplerenone in the Treatment of Central Serous Chorioretinopathy
  • Does Eplerenone Have a Future in the Management of Hypertension in Europe?
  • Indomethacin, Amiloride, Or Eplerenone for Treating Hypokalemia in Gitelman Syndrome
  • Spironolactone Shortage Updated 01 Sep 2017 Suppliers of Spironolactone Tablets in Canada1
  • Attachment 1. Product Information for Eplerenone
  • Package Leaflet: Information for the Patient Eplerenone 25 Mg Film
  • TREATMENT Anne BLANCHARDKDIGO / Olivier DEVUYST Disclosure of Interests
  • Pregabalin Lercanidipine Hydrochloride Ulipristal Acetate
  • Comparison Between Spironolactone and Eplerenone on LV Systolic Function in Patients with Chronic Heart Failure MD
  • Review of the Role of Spironolactone in the Therapy of Children
  • II. Molecular Docking, Spectral Data-Activity Relationship
  • Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
  • NG198 Evidence Review G


© 2024 Docslib.org    Feedback